Goldie Lui has 10 years of experience in the fields of precision medicine and oncology drug development, bridging research to and from the clinic to provide better therapies for patients. She is currently a Lead Scientist at SEngine Precision Medicine, a precision oncology company utilizing functional genomics, organoid technology, robotics, and AI-driven computational tools. Previously, she has held roles at Fred Hutchinson Cancer Research Center in Seattle and Pfizer in San Diego. She holds a PhD in cancer biology from the University of Sydney, Australia.